(Q33173818)

23 July 2017

1 reference

title

Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers (English)

1 reference

hypertrophic cardiomyopathy

23 July 2017

main subject

1 reference

Marian AJ

1

1 reference

23 July 2017

language of work or name

1 reference

1 April 1995

1 reference

23 July 2017

1 reference

23 July 2017

volume

18

1 reference

23 July 2017

issue

4

1 reference

23 July 2017

page(s)

189-198

1 reference

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Myosin isoenzymes in normal and hypertrophied human ventricular myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Myosin structure and function in cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Hypertrophic cardiomyopathy mutation is expressed in messenger RNA of skeletal as well as cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

Hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Causes of sudden death in competitive athletes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

The prevalence of hypertrophic cardiomyopathy in men: an echocardiographic population screening study with a review of death records

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Prognosis in hypertrophic cardiomyopathy observed in a large clinic population

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Long-term prognosis in children with hypertrophic cardiomyopathy: an analysis of 37 patients aged less than or equal to 14 years at diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

“Malignant” hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Hypertrophic cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

The Electrocardiogram in Asymmetric Septal Hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Diurnal change in QT intervals in dilated cardiomyopathy and hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

QT-interval abnormalities in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Signal-averaged electrocardiography in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

The prevalence of arrhythmias in hypertrophic cardiomyopathy: role of ambulatory monitoring and signal-averaged electrocardiography

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Late ventricular potentials and spontaneous and induced ventricular arrhythmias in dilated or hypertrophic cardiomyopathies. A prospective study about 83 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Asymmetrical hypertrophy of the heart in young adults

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Familial Prevalence and Genetic Transmission of Idiopathic Hypertrophic Subaortic Stenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Inheritance of hypertrophic cardiomyopathy: a cross sectional and M mode echocardiographic study of 50 families

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Functional sequences of the myosin head

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Three-dimensional structure of myosin subfragment-1: a molecular motor

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Structure of the actin-myosin complex and its implications for muscle contraction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Complete sequence and organization of the human cardiac beta-myosin heavy chain gene

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Molecular genetics. Therapy or terror?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Hypertrophic cardiomyopathy: long-term effects of propranolol versus verapamil in preventing sudden death in "low-risk" patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Sudden death due to ventricular tachycardia during amiodarone therapy in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

The automatic implantable cardioverter-defibrillator in young patients.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960180403

7 January 2021

Identifiers

DOI

10.1002/CLC.4960180403

1 reference

23 July 2017

1 reference